Related Experiment Video
Updated: Mar 29, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Tmem178 acts in a novel negative feedback loop targeting NFATc1 to regulate bone mass
Corinne E Decker1, Zhengfeng Yang2, Ryan Rimer3
1Department of Orthopaedic Surgery, Musculoskeletal Research Center, Washington University School of Medicine, St. Louis, MO 63110; Graduate Program in Immunology, Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO 63110;
Abstract:
Phospholipase C gamma-2 (PLCγ2)-dependent calcium (Ca(2+)) oscillations are indispensable for nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) activation and downstream gene transcription driving osteoclastogenesis during skeletal remodeling and pathological bone loss. Here we describe, to our knowledge, the first known function of transmembrane protein 178 (Tmem178), a PLCγ2 downstream target gene, as a critical modulator of the NFATc1 axis. In surprising contrast to the osteopetrotic phenotype of PLCγ2(-/-) mice, Tmem178(-/-) mice are osteopenic in basal conditions and are more susceptible to inflammatory bone loss, owing to enhanced osteoclast formation. Mechanistically, Tmem178 localizes to the ER membrane and regulates RANKL-induced Ca(2+) fluxes, thus controlling NFATc1 induction. Importantly, down-regulation of Tmem178 is observed in human CD14(+) monocytes exposed to plasma from systemic juvenile idiopathic arthritis patients. Similar to the mouse model, reduced Tmem178 expression in human cells correlates with excessive osteoclastogenesis. In sum, these findings identify an essential role for Tmem178 to maintain skeletal mass and limit pathological bone loss.
Insights
Transmembrane protein 178 (Tmem178) regulates calcium signaling essential for osteoclast formation. Loss of Tmem178 enhances bone loss, highlighting its role in maintaining skeletal mass and preventing pathological conditions.
Area of Science:
- Skeletal Biology
- Immunology
- Cell Signaling
Background:
- Phospholipase C gamma-2 (PLCγ2) signaling and calcium (Ca2+) oscillations are crucial for nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) activation, driving osteoclastogenesis.
- Osteoclastogenesis is vital for skeletal remodeling but also implicated in pathological bone loss.
Purpose of the Study:
- To identify the function of transmembrane protein 178 (Tmem178), a PLCγ2 downstream target, in regulating the NFATc1 axis.
- To investigate the role of Tmem178 in skeletal homeostasis and pathological bone loss.
Main Methods:
- Utilized knockout mouse models (Tmem178(-/-) and PLCγ2(-/-)) to assess skeletal phenotypes.
- Investigated Tmem178 localization and function in regulating calcium fluxes at the ER membrane.
- Analyzed human CD14(+) monocytes from patients with systemic juvenile idiopathic arthritis.
Main Results:
- Tmem178(-/-) mice exhibit osteopenia and increased susceptibility to inflammatory bone loss due to enhanced osteoclast formation, contrasting with PLCγ2(-/-) mice.
- Tmem178 localizes to the ER membrane and modulates RANKL-induced Ca2+ fluxes, thereby controlling NFATc1 induction.
- Down-regulation of Tmem178 in human monocytes correlates with excessive osteoclastogenesis, particularly in patients with systemic juvenile idiopathic arthritis.
Conclusions:
- Tmem178 acts as a critical modulator of the NFATc1 axis, essential for maintaining skeletal mass.
- Tmem178 plays a key role in limiting pathological bone loss by controlling osteoclast formation.
- Dysregulation of Tmem178 is linked to excessive osteoclastogenesis and bone loss in inflammatory conditions.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Bone Remodeling
Osteoclasts in Bone Remodeling
Master Transcription Regulators

